We are live on ! Find out more
ARMP icon

Armata Pharmaceuticals
ARMP

15 hedge funds and large institutions have $8.89M invested in Armata Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less capital invested

Capital invested by funds: $9.19M → $8.89M (-$301K)

6% less funds holding

Funds holding: 16 → 15 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$375K
2
BGA
Belmont Global Advisors
Texas
+$144K
3
Deutsche Bank
Deutsche Bank
Germany
+$13K
4
Morgan Stanley
Morgan Stanley
New York
+$12.3K
5
BFA
BlackRock Fund Advisors
California
+$3.06K

Top Sellers

Rank Fund Capital Flow
1
MP
MSD Partners
New York
-$387K
2
AC
Armistice Capital
New York
-$371K
3
RCM
RA Capital Management
Massachusetts
-$62.8K
4
Millennium Management
Millennium Management
New York
-$40K
5
PA
Perceptive Advisors
New York
-$28.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
TS
1
Third Security
Virginia
$4.61M – – –
BC
2
Broadfin Capital
New York
$2.2M – – –
MP
3
MSD Partners
New York
$808K -$387K -505 -26%
BGA
4
Belmont Global Advisors
Texas
$312K +$144K +188 +51%
PA
5
Perceptive Advisors
New York
$298K -$28.3K -37 -6%
Vanguard Group
6
Vanguard Group
Pennsylvania
$274K +$375K +490 New
RCM
7
RA Capital Management
Massachusetts
$213K -$62.8K -82 -18%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$70K – – –
Janney Montgomery Scott
9
Janney Montgomery Scott
Pennsylvania
$64K – – –
Morgan Stanley
10
Morgan Stanley
New York
$25K +$12.3K +16 +55%
Deutsche Bank
11
Deutsche Bank
Germany
$9K +$13K +17 New
LTFS
12
Ladenburg Thalmann Financial Services
Florida
$3K – – –
TRCT
13
Tower Research Capital (TRC)
New York
$2K +$766 +1 +50%
BFA
14
BlackRock Fund Advisors
California
$2K +$3.06K +4 New
AC
15
Armistice Capital
New York
– -$371K -670 Closed
Millennium Management
16
Millennium Management
New York
– -$40K -73 Closed
Citigroup
17
Citigroup
New York
– -$6K -11 Closed
TWA
18
TCI Wealth Advisors
Arizona
– -$3.06K -4 -80%
Walleye Trading
19
Walleye Trading
New York
– -$2K -4 Closed

ARMP Hedge Fund Activity: Q4 2015 in Review

15 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q4 2015, worth a combined $8.89M — down 3.3% from $9.19M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ARMP and 3 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 3 added.

The largest buyer was Vanguard Group, opening a new position worth an estimated $375K. The largest seller was MSD Partners, cutting an estimated $387K.

  • 15 institutional investors held Armata Pharmaceuticals (ARMP) as of Q4 2015, down from 16 in Q3 2015.
  • Funds reported $8.89M of Armata Pharmaceuticals stock for Q4 2015, down 3.3% quarter-over-quarter.
  • 3 funds opened new Armata Pharmaceuticals positions in Q4 2015 and 4 closed out, a net change of -1 holder.
  • The largest Armata Pharmaceuticals buyer in Q4 2015 was Vanguard Group, an estimated $375K added.
  • The largest Armata Pharmaceuticals seller in Q4 2015 was MSD Partners, an estimated $387K sold.

Based on aggregated 13F filings for Q4 2015.